[Table_CoverAuthor] 唐爱金 医药行业首席分析师 曹佳琳 医药行业分析师 S1500523080002 S1500523080011 tangaijin@cindasc.com caojialin@cindasc.com 证券研究报告 公司研究 [Table_ReportType] 公司深度报告 [Table_StockAndRank] 山外山(688410) 血透机国产龙头，"进口替代+出海+耗材放量"驱动成长 [Table_CoverStock] —山外山(688410)公司深度报告 [Table_ReportDate] 2026 年 1 月 16 日 投资评级 买入 上次评级 [Table_Chart] -20% 0% 20% 40% 60% 80% 100% 25/01 25/05 25/09 山外山 沪深300 资料来源：聚源，信达证券研发中心 [Table_BaseData] 公司主要数据 | 收盘价（元） | 16.00 | | --- | --- | | 52 周内股价波动区间 9.93-18.16 | | | (元) | | | 最近一月涨跌幅(％) | 10.27 | | ...

[Table_ReportType] 公司点评报告 [李Ta宁bl(e2_3St3o1c.kHAKn)dRank] | | | 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 刘田田 纺织服饰行业分析师 执业编号：S1500525120001 邮箱：liutiantian@cindasc.com CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 证券研究报告 公司研究 [Table_Title] Q4 流水微降库存健康，长期看奥运赞助夯实 信心 [Table_ReportDate] 2026 年 1 月 16 日 投资评级 无评级 上次评级 无评级 [姜Ta文b镪le_新Au消th费o行r]业首席分析师 [T事ab件le：_S李um宁ma发ry布]二零二五年第四季度最新运营情况公告。2025 年第四季度 李宁牌全渠道流水录得低单位数下降。分渠道看：线下整体中单位数下滑（批 发中单位数降，直营低单位数降）；电商渠道流水大致持平。直营表现略优 于批发，主要得益于奥莱等特价渠道清货力度大。店铺方面 ...

证券研究报告 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮 箱： jiangwenqiang@cindasc.com 骆峥 新消费行业分析师 执业编号：S1500525020001 邮 箱： luozheng1@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 六福集团(0590.HK) 投资评级 上次评级 [Table_Title] 六福集团：10-12 月同店增速环比加快，产品 结构持续优化 [Table_ReportDate] 2026 年 01 月 16 日 [Table_S 事件：六福集团发布 ummary] FY2026 第三季度零售销售表现公告。公司 2026 财年 第三季度（25 年 10-12 月）整体实现零售值同比+26%，其中内地同比+26%， 内地以外市场同比+20%，环比 7-9 月增速加快，趋势良好。 同店销 ...

睡眠经济方兴未艾，大单品驱动成长新篇 [Table_CoverStock] —罗莱生活(002293)公司首次覆盖报告 [Table_ReportDate] 2026 年 01 月 15 日 [姜Ta文bl镪e_CoverAuthor] 刘田田 S1500524120004 S1500525120001 jiangwenqiang@cindasc.com liutiantian@cindasc.com 公司研究 [Table_ReportType] 公司首次覆盖报告 [罗Ta莱bl生e_活Sto(c0k0A2n2d9Ra3n)k] [Table_Chart] 资料来源：聚源，信达证券研发中心 [公Ta司bl主e_要Ba数se据Data] | 收盘价（元） | 9.46 | | --- | --- | | 52 周内股价波动区间 | 12.05-7.75 | | (元) | | | 最近一月涨跌幅(％) | 0.19% | | 总股本(亿股) | 8.34 | | 流通 A 股比例(％) | 99.13 | | 总市值(亿元) | 78.88 | | 资料来源：聚源，信达证券研发中心 | | 信达证券股份有限公 ...

证券研究报告 | 一、海外需求并不弱 3 | | --- | | 二、港口集装箱吞吐量的回落，或对市场预期有干扰 5 | | 三、东盟等非美市场扩围，对冲了高基数的影响 6 | | 风险因素 8 | 宏观研究 [Table_ReportType] 专题报告 | [Table_A 解运亮 uthor宏观首席 | ] 分析师 | | --- | --- | | 执业编号：S1500521040002 | | | 联系电话：010-83326858 | | | 邮 | 箱：xieyunliang@cindasc.com | 麦麟玥 宏观分析师 执业编号：S1500524070002 邮 箱：mailinyue@cindasc.com 信达证券股份有限公司 CINDASECURITIESCO.,LTD 北京市西城区宣武门西大街甲127 号金隅 大厦B 座 邮编：100031 [Table_Title] 出口缘何再"超预期"？ [Table_ReportDate] 2026 年 1 月 15 日 请阅读最后一页免责声明及信息披露 http://www.cindasc.com 1 [➢Table_Summary] 第一， ...

Investment Rating - The investment rating for the pharmaceutical and biotechnology industry is "Positive" [2] Core Insights - The pharmaceutical sector experienced a weekly return of 7.81%, outperforming the CSI 300 index by 5.03%, ranking 6th among 31 primary sub-industry indices. The medical services sub-sector had the highest weekly increase of 12.34% [3][15] - The report highlights the impact of recent events such as Elon Musk's announcement regarding Neuralink's product mass production in 2026, Arrowhead Pharmaceuticals' promising clinical data for its siRNA therapy ARO-INHBE, and OpenAI's launch of "ChatGPT health," which have driven the sector's performance. The report suggests that while the brain-computer interface theme may be at a short-term emotional peak, AI medical applications still have room for growth [3][14] - Continuous investment in innovative drugs and related assets in the CXO and upstream life sciences sectors is recommended [3][14] Summary by Sections 1. Market Performance - The pharmaceutical sector's monthly return was 4.87%, outperforming the CSI 300 index by 1.37%, ranking 18th among 31 primary sub-industry indices. The medical services sub-sector had the highest monthly increase of 12.19% [15][20] 2. AI Medical Applications - AI applications in healthcare include AI+medical testing, AI+medical large models, AI+imaging, AI+e-commerce/precision marketing, and AI+gene sequencing, with notable companies such as KingMed Diagnostics, Dian Diagnostics, and BGI Genomics leading in these areas [4][16] 3. CXO and Upstream Life Sciences - Key global CXO leaders to watch include WuXi AppTec, WuXi Biologics, and Kelun Pharmaceutical. Domestic clinical CRO leaders include Tigermed and PPD. The report also highlights resource-based CXOs and upstream life sciences companies [5][16] 4. High-end Medical Devices - The report suggests focusing on companies involved in robotic applications, pharmaceutical equipment, and consumer medical devices, as demand is gradually recovering [5][16] 5. Innovative Drugs - Investment opportunities are identified in small nucleic acids, ADCs, and IO dual/multi-antibodies, with specific companies recommended for each category [6][16]

Investment Rating - The report maintains a "Positive" investment rating for the coal mining industry, consistent with the previous rating [2]. Core Insights - The current phase is viewed as the beginning of a new upward cycle for the coal economy, with a focus on the recovery of coal market conditions and value reassessment [3][5]. - Supply constraints are expected to re-emerge, with domestic coal production potentially declining due to regulatory checks and safety inspections [5][13]. - Demand for coal is projected to see slight growth in 2026, driven by a 5% economic growth rate and increased coal consumption in non-electric sectors [5][13]. - Short-term coal prices are expected to stabilize and potentially rise due to seasonal demand increases and inventory reductions at coastal ports [5][13]. Summary by Sections 1. Coal Prices - As of January 10, the market price for Qinhuangdao port thermal coal (Q5500) is 696 CNY/ton, up 17 CNY/ton week-on-week [4][32]. - The price for coking coal at Jingtang port remains stable at 1650 CNY/ton [34]. - International thermal coal prices show slight increases, with Newcastle coal at 71.8 USD/ton, up 0.3 USD/ton week-on-week [4][32]. 2. Supply and Demand Dynamics - The capacity utilization rate for thermal coal mines is reported at 90.3%, an increase of 8.2 percentage points week-on-week [5][13]. - Demand from coastal provinces has increased, with daily consumption rising by 29.9 thousand tons (+15.11%) [5][13]. - Chemical coal consumption has also increased, with a weekly rise of 8.36 thousand tons (+1.13%) [5][13]. 3. Market Outlook - The report emphasizes the importance of coal supply as a stabilizing factor in the market, with expected regulatory constraints leading to a tighter supply environment [5][13]. - The anticipated recovery in coal prices and the potential for value reassessment in the sector are highlighted as key investment themes [5][13]. - The report suggests that the coal sector remains an attractive investment opportunity, particularly for high-quality coal companies with strong cash flows and dividend yields [5][15].

Investment Rating - The investment rating for the mechanical equipment industry is "Positive" [2] Core Insights - The commercial aerospace sector is accelerating, and the demand for AI infrastructure remains strong, indicating potential investment opportunities in these areas [11][12] - The performance of excavators and other construction machinery is showing a significant recovery, with notable increases in both domestic and export sales [13][73] Company Summaries 1) Rilian Technology - Rilian Technology is a leading domestic supplier of industrial X-ray intelligent detection equipment and core components, establishing significant technological barriers in core components, AI software, and detection equipment. In the first three quarters of 2025, the company's revenue grew by 44.01% year-on-year, and net profit attributable to shareholders increased by 18.83%. The slower profit growth compared to revenue is attributed to costs related to new production bases and employee stock incentives. The company is expected to convert orders into revenue effectively, leading to profit elasticity release as cost impacts diminish [3][14]. 2) Konstar - Konstar focuses on the research and sales of digital testing instruments. Despite facing performance pressure from tariffs, the company saw a positive turning point in Q3 2025, with revenue reaching 148 million yuan, a year-on-year increase of 22.24%, and net profit attributable to shareholders growing by 30.66%. The company demonstrates strong operational resilience in international markets under tariff pressures, and its domestic business is performing well, with growth potential in MEMS sensors [4][15]. 3) Xinxin Co., Ltd. - Xinxin Co., Ltd. specializes in hard alloys and tools, reporting a revenue growth of 38.02% and a net profit increase of 75.40% in Q3 2025. The company is experiencing accelerated growth in both revenue and profit, driven by effective cost management amid rising raw material prices [5][16]. Industry Trends - The demand for AI-related infrastructure continues to thrive, with significant investments in AI technologies and related supply chains expected to benefit from this trend [12]. - The construction machinery sector is witnessing a comprehensive recovery, with excavator sales reaching 23,095 units in December 2025, a year-on-year increase of 19.2%, and loader sales growing by 30.00% [13][73].

Investment Rating - The industry investment rating is "Positive" [2] Core Viewpoints - The release of the Nvidia Rubin platform marks a new era in AI computing power, with a complete transformation of global computing facilities towards the "AI factory" paradigm [3][39] - The Rubin platform features six new chips designed for AI supercomputers, significantly enhancing inference performance and reducing training costs [3][7] - The introduction of open-source models expands Nvidia's ecosystem, covering various fields including biomedical AI, physical AI, and autonomous driving [3][29] Summary by Sections Chip Performance - The Rubin GPU introduces a Transformer engine, achieving inference performance of 50 PFLOPS, which is five times that of the Blackwell GPU, while training performance reaches 35 PFLOPS, 3.5 times that of Blackwell [3][13] - The Vera CPU is designed for data movement and intelligent processing, featuring 88 custom Nvidia cores and a system memory of 1.5 TB, which is three times that of the Grace CPU [3][12] Storage Solutions - The Rubin platform addresses KV Cache issues with a new inference context memory storage platform, significantly enhancing memory performance and efficiency [3][18] - Each Rubin GPU can be equipped with up to 288 GB of HBM4, with total memory bandwidth increased to 22 TB/s, 2.8 times that of Blackwell [3][14] PCB and Rack Innovations - The transition to a cableless interconnect architecture in the Rubin NVL72 PCB significantly reduces assembly time by 18 times and lowers operational costs [3][22] - The system's collaborative design enhances efficiency, allowing for a reduction in the number of GPUs needed for training large models by 75% compared to the previous generation [3][25] Open Source Models - The expansion of Nvidia's open-source model ecosystem includes updates across six major areas, with a focus on the Nemotron series for various applications [3][32] - The Nemotron series includes models for inference, retrieval-augmented generation, safety, and speech processing [3][32] Physical AI Developments - The Cosmos model is designed for understanding and generating physical world videos, while Alpamayo serves as an open-source toolchain for autonomous driving, introducing reasoning capabilities [3][33][34]

Investment Rating - The report maintains a "Positive" investment rating for the oil processing industry [1]. Core Insights - The international oil prices experienced a rebound due to geopolitical tensions, particularly involving Venezuela and Iran, with Brent and WTI prices reaching $63.34 and $59.12 per barrel, respectively, as of January 11, 2026 [2][9]. - The report highlights a significant increase in U.S. crude oil imports, which rose by 27.98% to 6.339 million barrels per day, while exports increased by 23.92% to 4.263 million barrels per day, resulting in a net import increase of 37.21% [47]. - The oil and petrochemical sector showed a mixed performance, with the sector rising by 0.29% while the broader market (CSI 300) increased by 2.79% [10]. Summary by Sections Oil Price Review - As of January 9, 2026, Brent crude futures settled at $63.34 per barrel, up $2.59 (+4.26%) from the previous week, while WTI crude futures rose to $59.12 per barrel, an increase of $1.80 (+3.14%) [26]. Offshore Drilling Services - The number of global offshore self-elevating drilling rigs remained stable at 376, and floating drilling rigs also held steady at 129 as of January 5, 2026 [32]. Crude Oil Supply - U.S. crude oil production was reported at 13.811 million barrels per day, a decrease of 16,000 barrels from the previous week, with active drilling rigs down to 409 [42]. Crude Oil Demand - U.S. refinery crude processing increased to 16.909 million barrels per day, with a refinery utilization rate of 94.70%, unchanged from the previous week [50]. Crude Oil Inventory - Total U.S. crude oil inventories decreased by 3.587 million barrels (-0.43%) to 833 million barrels as of January 2, 2026, with commercial inventories down by 3.832 million barrels (-0.91%) [62]. Refined Oil Products - As of January 9, 2026, U.S. average prices for diesel, gasoline, and jet fuel were $88.99, $72.69, and $78.96 per barrel, respectively, with varying price changes compared to the previous week [85].